By Matthew Guarnaccia ( June 10, 2019, 1:24 PM EDT) -- Merck said Monday it would acquire Wilson Sonsini-led biopharmaceutical firm Tilos Therapeutics in a deal worth as much as $773 million, adding a business focused on treatments for cancer, fibrosis and autoimmune diseases as it continues a recent buying spree....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.